Business Context and Reporting Period
Company: SANUWAVE Health, Inc. (SNWV)
Filing Type: Form 8-K (Current Report)
Date of Report: March 21, 2025
Reporting Period: Fourth quarter and fiscal year ended December 31, 2024
The Company issued a press release on March 21, 2025, announcing its financial results for the fourth quarter and full fiscal year 2024. A business update conference call was scheduled for March 21, 2025, at 8:30 am EST.
Key Financial Metrics
The provided filing text serves as a notification of the results announcement and does not contain specific numerical data. The following metrics are not disclosed in this document:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt and Liquidity
Investors are directed to the attached press release (Exhibit 99.1) and the Company's investor website for detailed financial figures.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance compared to prior periods. It only confirms that results for the fourth quarter and fiscal year 2024 have been announced.
Guidance, Outlook, and Risks
Management Commentary: The Company indicated that a business update would be provided via a conference call on the date of the filing.
Guidance and Risks: No specific forward-looking guidance, risk factors, or contingencies are detailed within the text of this Form 8-K. The document explicitly states that the information in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific revenue, profit, and cash flow numbers for Q4 and FY 2024.
- Access the Company's investor website (www.sanuwave.com/investors) for the full presentation materials and conference call transcript.
- Verify the Company's liquidity position and debt levels in the detailed financial statements referenced in the press release.
- Confirm any updated guidance or strategic outlook provided during the March 21, 2025, conference call.